Human beta-defensin-3 (HBD-3) is an antimicrobial peptide with bactericidal effects on many gram-positive and gram-negative bacteria and some yeast species and, if radiolabeled, might be used to distinguish bacterial infection from sterile inflammation. The goals of the present study were to develop methods for radiolabeling HBD-3 with Tc-99m and to perform preliminary investigations on Tc-99m-labeled HBD-3 as a means to evaluate induced infection in an animal model. To this purpose, Staphylococcus aureus-induced infection was used to evaluate the capability of Tc-99m-HBD-3 to distinguish infection from aseptic inflammation in rats. Methods: Twenty to 40 mu g of recombinant HBD-3 were labeled with Tc-99m(+) hexa-coordinated with 3 molecules of CO and H2O and separated by a column from free Tc-99m. Tc-99m-HBD-3 was added to cultures of a bacterial suspension of S. aureus and Escherichia coli to evaluate in vitro antibacterial activity. A bacterial suspension of S. aureus and a carrageenan solution were used to induce infection and sterile inflammation, respectively, in opposite thighs of 9 adult rats. Three separate experiments were performed on groups of 3 rats each. The animals received different doses of Tc-99m-HBD-3 injected through a cannula into the jugular vein. After sacrifice of the animals, tissue samples were obtained from sites of infection, inflammation, and control muscle (left foreleg) at 1, 3, and 5 h after Tc-99m-HBD-3 administration. Tissue samples were weighed and then counted in a well-counter. Simultaneously, 1 mL of a standard solution of Tc-99m-HBD-3 corresponding to each administered dose was counted. Results: Tc-99m-HBD-3 retained antibacterial activity. Radioactivity in tissue samples from the infected sites was significantly higher than that in samples of either induced inflammation or normal control muscle (ratio, similar to 3:1) at 3 and 5 h after injection, whereas similar radioactivity counts were observed for tissue samples from aseptic inflammation sites and normal control muscle. Conclusion: In this investigation, Tc-99m-HBD-3 retained antibacterial activity and successfully distinguished infection from aseptic inflammation in adult rats.

Microbial Targeting of Tc-99m-Labeled Recombinant Human beta-Defensin-3 in an Animal Model of Infection: A Feasibility Pilot Study / Liberatore, Mauro; Pala, Alessandro; Scaccianoce, Sergio; C., Anagnostou; DI TONDO, Ugo; Calandri, Enrico; P., D'Elia; M. D., Gross; D., Rubello. - In: THE JOURNAL OF NUCLEAR MEDICINE. - ISSN 0161-5505. - STAMPA. - 50:(2009), pp. 823-826. [10.2967/jnumed.108.055533]

Microbial Targeting of Tc-99m-Labeled Recombinant Human beta-Defensin-3 in an Animal Model of Infection: A Feasibility Pilot Study

LIBERATORE, Mauro;PALA, Alessandro;SCACCIANOCE, Sergio;DI TONDO, Ugo;CALANDRI, ENRICO;
2009

Abstract

Human beta-defensin-3 (HBD-3) is an antimicrobial peptide with bactericidal effects on many gram-positive and gram-negative bacteria and some yeast species and, if radiolabeled, might be used to distinguish bacterial infection from sterile inflammation. The goals of the present study were to develop methods for radiolabeling HBD-3 with Tc-99m and to perform preliminary investigations on Tc-99m-labeled HBD-3 as a means to evaluate induced infection in an animal model. To this purpose, Staphylococcus aureus-induced infection was used to evaluate the capability of Tc-99m-HBD-3 to distinguish infection from aseptic inflammation in rats. Methods: Twenty to 40 mu g of recombinant HBD-3 were labeled with Tc-99m(+) hexa-coordinated with 3 molecules of CO and H2O and separated by a column from free Tc-99m. Tc-99m-HBD-3 was added to cultures of a bacterial suspension of S. aureus and Escherichia coli to evaluate in vitro antibacterial activity. A bacterial suspension of S. aureus and a carrageenan solution were used to induce infection and sterile inflammation, respectively, in opposite thighs of 9 adult rats. Three separate experiments were performed on groups of 3 rats each. The animals received different doses of Tc-99m-HBD-3 injected through a cannula into the jugular vein. After sacrifice of the animals, tissue samples were obtained from sites of infection, inflammation, and control muscle (left foreleg) at 1, 3, and 5 h after Tc-99m-HBD-3 administration. Tissue samples were weighed and then counted in a well-counter. Simultaneously, 1 mL of a standard solution of Tc-99m-HBD-3 corresponding to each administered dose was counted. Results: Tc-99m-HBD-3 retained antibacterial activity. Radioactivity in tissue samples from the infected sites was significantly higher than that in samples of either induced inflammation or normal control muscle (ratio, similar to 3:1) at 3 and 5 h after injection, whereas similar radioactivity counts were observed for tissue samples from aseptic inflammation sites and normal control muscle. Conclusion: In this investigation, Tc-99m-HBD-3 retained antibacterial activity and successfully distinguished infection from aseptic inflammation in adult rats.
2009
adult rats; antimicrobial cationic peptides; infection; inflammation; peptide imaging
01 Pubblicazione su rivista::01a Articolo in rivista
Microbial Targeting of Tc-99m-Labeled Recombinant Human beta-Defensin-3 in an Animal Model of Infection: A Feasibility Pilot Study / Liberatore, Mauro; Pala, Alessandro; Scaccianoce, Sergio; C., Anagnostou; DI TONDO, Ugo; Calandri, Enrico; P., D'Elia; M. D., Gross; D., Rubello. - In: THE JOURNAL OF NUCLEAR MEDICINE. - ISSN 0161-5505. - STAMPA. - 50:(2009), pp. 823-826. [10.2967/jnumed.108.055533]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/362180
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 18
social impact